Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,252 | 9,900 | 10,098 | 5,482 | 10,370 |
| Gross Profit | 2,252 | 9,900 | 10,098 | 5,482 | 10,370 |
| Operating Expenses | 20,000 | 28,606 | 24,149 | 26,387 | 27,097 |
| Operating Income | -17,748 | -18,706 | -14,051 | -20,905 | -16,727 |
| Interest Expense | 36 | 13 | 3 | 3 | 7 |
| Other Income | 471 | 409 | 238 | 163 | 8 |
| Pre-tax Income | -17,313 | -18,310 | -13,816 | -20,745 | -16,726 |
| Income Tax | N/A | N/A | -130 | -119 | N/A |
| Net Income Continuous | -17,313 | -18,310 | -13,686 | -20,626 | -16,726 |
| Net Income | $-17,313 | $-18,310 | $-13,686 | $-20,626 | $-16,726 |
| EPS Basic Total Ops | -4.23 | -4.41 | -2.88 | -6.21 | -5.13 |
| EPS Basic Continuous Ops | -4.19 | -4.44 | -2.89 | -6.20 | -5.15 |
| EPS Diluted Total Ops | -4.23 | -4.41 | -2.88 | -6.21 | -5.13 |
| EPS Diluted Continuous Ops | -4.19 | -4.44 | -2.89 | -6.20 | -5.15 |
| EBITDA(a) | $-17,445 | $-18,372 | $-13,708 | $-20,548 | $-16,380 |